Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-02-16 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +18,750 427,500
2012-02-16 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +12,500 440,000
2012-02-16 Polymeropoulos Mihael Hristos President and CEO Sale −11,350 $4.69 $53K 428,650
2012-02-16 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion · Restricted Stock Unit −18,750 37,500
2012-02-16 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion · Restricted Stock Unit −12,500 37,500
2012-02-16 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion +12,500 17,500
2012-02-16 Kelly James Patrick SVP, CFO, Sec & Treasurer Sale −4,920 $4.67 $23K 12,580
2012-02-16 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion · Restricted Stock Unit −12,500 37,500
2012-02-16 Feeney John Joseph SVP & Chief Medical Officer Exercise or conversion +7,500 15,000
2012-02-16 Feeney John Joseph SVP & Chief Medical Officer Exercise or conversion +4,687 19,687
2012-02-16 Feeney John Joseph SVP & Chief Medical Officer Sale −4,760 $4.65 $22K 14,927
2012-02-16 Feeney John Joseph SVP & Chief Medical Officer Exercise or conversion · Restricted Stock Unit −7,500 15,000
2012-02-16 Feeney John Joseph SVP & Chief Medical Officer Exercise or conversion · Restricted Stock Unit −4,687 14,063
2011-12-06 Feeney John Joseph SVP & Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +56,250 56,250
2011-12-06 Feeney John Joseph SVP & Chief Medical Officer Grant or award · Restricted Stock Units +18,750 18,750
2011-08-23 Polymeropoulos Mihael Hristos President and CEO Purchase +7,920 $5.35 $42K 408,750
2011-08-22 Polymeropoulos Mihael Hristos President and CEO Purchase +2,080 $5.34 $11K 400,830

Page 36 of 36 · 717 trades